Evidence map›Paper›PMID 32163369›Full record

ArticleTurkish thoracic journal2020

Re: Nicotine Delivery of E-Cigarettes.

Dilek Aslan, Aylin Gürbay, Mutlu Hayran, Meltem Şengelen, Duygu Paslı, Beril Hüseyin

Abstract read
In one paragraph

Article in Turkish thoracic journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dilek AslanDepartment of Public Health, Hacettepe University School of Medicine, Ankara, Turkey.ORCID http://orcid.org/0000-0002-4053-2517
Aylin GürbayDepartment of Pharmaceutical Toxicology, Hacettepe University Faculty of Pharmacy, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8571-1092
Mutlu HayranDepartment of Preventive Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.ORCID http://orcid.org/0000-0003-2594-6794
Meltem ŞengelenDepartment of Public Health, Hacettepe University School of Medicine, Ankara, Turkey.ORCID http://orcid.org/0000-0002-8257-765X
Duygu PaslıDepartment of Pharmaceutical Toxicology, Hacettepe University Faculty of Pharmacy, Ankara, Turkey.ORCID http://orcid.org/0000-0002-7566-646X
Beril HüseyinDepartment of Preventive Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.ORCID http://orcid.org/0000-0003-4421-7650

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32163369
PMCPMC7020898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.